OncoSystem Directory
Explore organizations in the global Oncology ecosystem
724 organization(s) found
Prague Metabolism Symposium
The group that organizes the Prague Metabolism and Signaling Symposium
Prague, Czech Republic
WebsitePredicta Biosciences
Advanced biopsy and reporting technology: Our approach delivers unprecedented sensitivity, accuracy, and informativity for diagnostics of multiple myeloma and other plasma cell dyscrasias. Our platform leverages whole genome sequencing (WGS) of cells isolated from both bone marrow and blood, providing significantly enhanced sensitivity and a wealth of diagnostic information compared to traditional bone marrow FISH assays. This enables more accurate diagnoses and earlier disease intervention.
Precision Diagnostics for Blood Cancers Cambridge, MA, United States WebsitePrincess Máxima Center
The Princess Máxima Center is not an ordinary hospital, but a research hospital. All children with cancer in the Netherlands are treated here. This makes the Princess Máxima Center the largest pediatric cancer center in Europe. Over 600 researchers and 900 healthcare professionals work closely with Dutch and international hospitals on better treatments and new perspectives on cures. In this way, we give the child of today the very best care and take important steps to improve the chances of survival for the children who are not yet cured.
Pediatric Oncology Utrecht, Netherlands WebsitePriothera
Extending and enhancing the quality of life and radically transforming the treatment of patients with hematological malignancies
Small-molecule drugs and CAR-T therapies for treatment of Leukemia, Autoimmune Disorders and other diseases Saint-Louis, France WebsiteProEn Therapeutics
ProEn Therapeutics Inc. is a new drug development company that focuses on oncology, and that contributes to the healthy life of mankind through biopharmaceuticals developed for protein engineering.
Bispecific ADCs, immune-cell engagers and CAR therapies for Oncology Sujeong-gu, Seongnam-si, Gyeonggi-do, South Korea WebsiteProject Pink Blue – Nigera
Nonprofit engaged in raising cancer awareness, patient navigation, advocacy and free breast and cervical cancer screening; launched Nigeria’s first patient-navigation service and toll-free cancer hotline.
Abuja, Nigeria WebsiteProvidence Therapeutics
Providence Therapeutics is an mRNA medicines company developing transformative cancer immunotherapies and protection from hard-to-treat infectious diseases. Our therapeutics come from a fully integrated, end-to-end Research and Development Ecosystem combining target discovery, our proprietary mRNA platform, INTENT� lipid nanoparticle platform (LNP), and a proven mRNA-LNP manufacturing platform applicable to fully personalized medicine all the way to pandemic scale manufacturing.
mRNA cancer vaccines and immunotherapies Calgary, AB, Canada WebsitePSCC
The Paris Saclay Cancer Cluster (PSCC) is an internationally renowned biocluster to accelerate oncology innovation
Innovation Villejuif, France WebsiteQidong Liver Cancer Institute / Qidong Cancer Registry
Focused on liver-cancer epidemiology and registry; represents regionally oriented cancer surveillance and research outside major megacities. (publications.iarc.who.int)
Qidong, China WebsiteQure Biotechnology
QureBio Ltd. was established in July 2017 and aims to develop novel therapeutic drugs for the treatment of tumors, autoimmune diseases and metabolic diseases in China and around the world to benefit patients. The company has multiple technology platforms for antibody drug development including phage display, hybridoma as well as protein and antibody engineering. In addition, the company's goal is to make an effective and robust manufacturing process for biologics.
Macromolecular drugs for Oncology (solid tumors amd blood cancers), Autoimmune Diseases and Metabolic Diseases Shanghai, China WebsiteRCI (Rwanda Cancer Institute)
Provides cancer treatment, research, and training across Rwanda.
Kigali, Rwanda WebsiteRegeneron
We are a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, almost all of which were homegrown in our laboratories. Regeneron's medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases and rare diseases.
New medicines for multiple and diverse therapeutic areas Tarrytown, NY, United States WebsiteRemeGen
RemeGen is committed to the discovery, development, production and commercialization of first-in-class and best-in-class biological drugs, and has developed a series of innovative biologics with significant clinical value for major diseases such as autoimmunity, oncology, and ophthalmology.
Biologics for Oncology, Autoimmune Diseases and Ophthalmologic Diseases Yantai, Shandong, China WebsiteResilience Care
At Resilience Care, we believe that digital innovation can transform the way we deliver care � making it more patient-centered, personalized and equitable. Our story, vision, and team reflect a shared commitment: to deliver better care by placing patients at the heart of care and clinical research.
Oncology, Psychiatry, Gastroenterology, Digital Health Biarritz, France WebsiteRevolution Medicines
We are Revolutionaries – passionate in our singular pursuit of discovering, developing and delivering innovative, targeted medicines for patients living with cancer. To deliver on our vision, we work relentlessly in pursuit of cutting-edge therapeutic approaches to some of the toughest cancers. Our current focus is on RAS-addicted cancers, which account for 30 percent of all new human cancer diagnoses. With our deep pipeline of RAS(ON) inhibitors, we are pioneering a new way of drugging the previously undruggable, with the potential to change the treatment paradigm for many patients living with RAS-addicted cancer.
Tri-complex inhibitors of RAS(ON) for treatment of solid tumors Redwood City, CA, United States WebsiteRoche
We focus on discovering new medicines, diagnostics and digital products that improve health outcomes, so that we all have more time with the people we love.
Oncology, Hematology, Cardiovascular, Renal & Metabolism, Immunology
Neuroscience, Ophthalmology, Other Basel, Switzerland WebsiteRoche Diagnostics (a member of the Roche group)
Roche Diagnostics empowers researchers and clinicians by providing one of the industry's most comprehensive testing portfolio of innovative diagnostic solutions, encompassing clinical chemistry and immunoassays to point of care testing and laboratory automation.
Oncology, Cardiometabolic Diseases, Infectious Diseases, Neurology, Women's health Rotkreuz, Switzerland Website